Potassium Chloride Injection Recalled Due to Pinhole Container Defects
B. Braun Medical is recalling 22,752 bags of Potassium Chloride for Injection Concentrate nationwide due to pinholes in container bags that compromise sterility assurance. Affected lots are J2S007 (expires 12/31/2024) and J3A115 (expires 01/31/2025).
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II parenteral drug recall involves a sterility assurance failure caused by container defects. No hospitalizations or illnesses have been reported, meeting the rubric criterion for High severity: a risk-of-harm product where injury has not yet been reported.
Plain-English summary
B. Braun Medical Inc. is recalling Potassium Chloride for Injection Concentrate USP (500 mEq/250 mL) in 250 mL bags distributed nationwide. The recall is due to pinholes within the blue label characters on EXCEL bags that can cause leaks and compromise the sterility assurance of the product.
The recall affects 22,752 bags in two manufacturing lots: Lot #J2S007 with expiration date 12/31/2024 and Lot #J3A115 with expiration date 01/31/2025. Healthcare facilities and patients should verify lot numbers and expiration dates of any potassium chloride injection concentrates in their possession.
Persons who may have been exposed to or used a recalled bag should contact their healthcare provider. Any adverse effects related to this product should be reported to the FDA's MedWatch program. B. Braun Medical Inc. is based in Bethlehem, Pennsylvania.
The recalled product
- Product
- POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
- Brand
- POTASSIUM CHLORIDE
- Manufacturer
- B. Braun Medical Inc
- Category
- Drug — Injectable
- Hazard
- sterility-failure
- container-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: J2S007
- Exp: 12/31/2024
- J3A115
- Exp: 01/31/2025.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · POTASSIUM CHLORIDE
- SeverePotassium Chloride Injection Recalled Nationwide for Mislabeled Strength
FDA (Drugs) · 2025-11-26
- CriticalPotassium Chloride Injection Recalled for Incorrect Strength on Overwrap Label
FDA (Drugs) · 2025-11-26
- SeverePotassium Chloride Injection Strength Mislabeled on Packaging Overwrap
FDA (Drugs) · 2025-03-19
- SeverePotassium Chloride Injection Recalled: Overwrap Labeling Shows Incorrect Strength
FDA (Drugs) · 2025-03-19
- HighPotassium Chloride Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-02-12
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27